Richard W. Pascoe - 04 Jan 2024 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
Director
Signature
/s/ Michael Golembiewski, as attorney-in-fact for Richard W. Pascoe
Issuer symbol
N/A
Transactions as of
04 Jan 2024
Net transactions value
$0
Form type
4
Filing time
08 Jan 2024, 21:46:09 UTC
Previous filing
13 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +1,666 $0.000000 1,666 04 Jan 2024 Common Stock 1,666 $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option shall vest on February 4, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter.